Paper39754692
Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study.
Manipis K and 5 others. Pharmacoeconomics, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study. Papers, record 39754692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39754692
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Foodborne Diseases | Major topic |
| Efficiency | Major topic |
| Models, Economic | Major topic |
| Cost of Illness | Major topic |
| Campylobacter Infections | Major topic |
| Humans | |
| Cost-Benefit Analysis | |
| Markov Chains | |
| Quality-Adjusted Life Years | |
| Sick Leave |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33389332 | Employer survey to estimate the productivity friction period. | Eur J Health Econ | 2021 | https://conductscience.org/library/papers/33389332 | PubMed |
| 2 | 10172868 | A practical guide for calculating indirect costs of disease. | Pharmacoeconomics | 1996 | https://conductscience.org/library/papers/10172868 | PubMed |
| 3 | 22980013 | Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. | J Food Prot | 2012 | https://conductscience.org/library/papers/22980013 | PubMed |
| 4 | 35977755 | Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China. | BMJ Glob Health | 2022 | https://conductscience.org/library/papers/35977755 | PubMed |
| 5 | 24676898 | A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. | Qual Life Res | 2014 | https://conductscience.org/library/papers/24676898 | PubMed |
| 6 | 17685356 | Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. | J Food Prot | 2007 | https://conductscience.org/library/papers/17685356 | PubMed |
| 7 | 23620213 | Productivity costs in economic evaluations: past, present, future. | Pharmacoeconomics | 2013 | https://conductscience.org/library/papers/23620213 | PubMed |
| 8 | 26431458 | Change in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort Study. | PLoS One | 2015 | https://conductscience.org/library/papers/26431458 | PubMed |
| 9 | 24523597 | The epidemiology of irritable bowel syndrome. | Clin Epidemiol | 2014 | https://conductscience.org/library/papers/24523597 | PubMed |
| 10 | 16967055 | Health state utilities for metastatic breast cancer. | Br J Cancer | 2006 | https://conductscience.org/library/papers/16967055 | PubMed |
| 11 | 34913141 | In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era. | Pharmacoeconomics | 2022 | https://conductscience.org/library/papers/34913141 | PubMed |
| 12 | 17645678 | Economic evaluation of tegaserod vs. placebo in the treatment of patients with irritable bowel syndrome: an analysis of the TENOR study. | Value Health | 2007 | https://conductscience.org/library/papers/17645678 | PubMed |
| 13 | 19491835 | Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort. | Am J Gastroenterol | 2009 | https://conductscience.org/library/papers/19491835 | PubMed |
| 14 | 32531958 | A Systematic Review Exploring the Economic Valuation of Accessing and Using Green and Blue Spaces to Improve Public Health. | Int J Environ Res Public Health | 2020 | https://conductscience.org/library/papers/32531958 | PubMed |
| 15 | 33625624 | Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study. | Eur J Health Econ | 2021 | https://conductscience.org/library/papers/33625624 | PubMed |
| 16 | 23834790 | Cost-effectiveness of interventions to control Campylobacter in the New Zealand poultry meat food supply. | J Food Prot | 2013 | https://conductscience.org/library/papers/23834790 | PubMed |
| 17 | 30384792 | Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations. | J Med Econ | 2019 | https://conductscience.org/library/papers/30384792 | PubMed |
| 18 | 23095351 | Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care. | BMC Gastroenterol | 2012 | https://conductscience.org/library/papers/23095351 | PubMed |
| 19 | 30254230 | Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem. | Am J Gastroenterol | 2018 | https://conductscience.org/library/papers/30254230 | PubMed |
| 20 | 19603025 | Societal preference values for advanced melanoma health states in the United Kingdom and Australia. | Br J Cancer | 2009 | https://conductscience.org/library/papers/19603025 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42350314 | Measuring, valuing, and incorporating patient and caregiver productivity costs in economic evaluations: a scoping review and environmental scan. | Int J Technol Assess Health Care | 2026 | https://conductscience.org/library/papers/42350314 | PubMed |
| 40871309 | Persistent Threats: A Comprehensive Review of Biofilm Formation, Control, and Economic Implications in Food Processing Environments. | Microorganisms | 2025 | https://conductscience.org/library/papers/40871309 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39754692
GET https://conductscience.org/api/papers/v1/39754692/references?page=2